Romero and co-workers suggested in 2014 a stepwise counting strategy without fixed denominators, especially to target heterogenetic tumours with some highly proliferative hotspots [29] and the International Ki67 Breast Cancer Working Group has proposed a standardized visual scoring method using a scoring app available online [13]. This evidence concerns the gene MKI67 and breast cancer.